The Agency for Healthcare Research and Quality (AHRQ), through its Evidence-based Practice Centers (EPCs), sponsors the development of evidence reports and technology assessments to assist public-and private-sector organizations in their efforts to improve the quality of health care in the United States.
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Introduction
The field of systematic reviews has principally developed in response to the needs of clinicians, guideline groups, professional societies, and policy-makers, who required evidence summaries to answer clinical questions and underpin guidelines or policies. However, health care in the U.S. is increasingly delivered by large health systems involving one or more hospitals and clinical practice sites. This trend offers an opportunity to develop evidence synthesis products (e.g., systematic reviews, rapid reviews) to support these systems in their efforts to provide high quality evidence-based care, improve quality, and conduct practice-based research. Furthermore, the movement toward value-based purchasing and increased requirements for quality reporting is likely to increase the utility of evidence synthesis on a broad range of topics that extend beyond questions of clinical efficacy to questions about alternative strategies for improving health care delivery, product and practice standardization, patient safety and quality of care.
The Agency for Healthcare Research and Quality (AHRQ) has made working with health systems a priority, with a focus on helping systems transition to learning health systems. A learning health system was defined by the Institute of Medicine (IOM, now the National Academy of Medicine) Roundtable on Evidence-based Medicine as a system "designed to generate and apply the best evidence for the collaborative health care choices of each patient and provider; to drive the process of discovery as a natural outgrowth of patient care; and to ensure innovation, quality and value in health care." 1 Well-established evidence synthesis programs such as the AHRQ Evidence-based Practice Center (EPC) Program have produced evidence reviews for more than two decades. These reviews have come to be recognized as a standard for rigor and quality across many disciplines, covering a wide range of topics that can be relied upon when making important decisions. This expertise may be particularly important when addressing high value care and health care delivery, which are likely to be complex in nature. Moreover, the EPC Program has developed considerable expertise in performing systematic reviews of complex multicomponent interventions. [2] [3] [4] [5] [6] [7] [8] [9] However, the program has not previously examined the scope of topics for which health systems seek evidence or how health systems access and use evidence-for what types of decisions and at what point in the decisionmaking process.
Of 250 reports produced by the EPC Program since 2011, 40 (16%) address care delivery and population health topics that may be of interest to health systems (e.g., patient-centered medical homes, medication adherence, quality improvement strategies), and 159 (64%) address clinical conditions that many health systems encounter. The remainder of topics covered methodologic issues of greatest interest to systematic reviewers. Previous work with health system representatives has revealed a need for evidence synthesis products that address specific decisions that health system leaders make and can be prepared quickly (e.g. evidence inventories, rapid reviews, automated approaches). 10 Similarly, a study of health technology assessments (HTAs) produced by nine agencies during [2003] [2004] [2005] [2006] 11 suggested that decisions about governance, financial, and delivery arrangements require research evidence that informs problem definition, option framing and assessment, and implementation plans. These studies support the notion that health systems have unique evidence needs and that formats developed for clinical guideline developers may not meet the needs of health systems.
Evidence synthesis producers need to strengthen their partnerships with health systems to better understand their evidence synthesis needs. Strengthening such partnerships requires a conceptual framework that clarifies and categorizes their evidence needs. Such a framework 1 could help the program and EPC researchers focus on the most appropriate evidence synthesis products for specific health systems.
The goal of this report is to present a conceptual framework to facilitate understanding of the potential areas for interaction between the EPC program and health systems. The framework categorizes the evidence needs of health systems, focusing largely on system use of external (i.e., published research) evidence. In addition, we explore the evidentiary needs and preferences for information presentation from health systems leaders participating in this project.
Methods
This project was commissioned by AHRQ as a methods project. The need for this project became apparent from years of EPCs' experience working with health systems, discussions with EPC Directors, EPC Methods Steering Committee meetings, and discussions with AHRQ leadership. This work is one of several complementary AHRQ projects about Learning Health Systems, including AHRQ's Comparative Health System Performance Initiative, which was designed to study how health care delivery systems promote evidence-based practices in care delivery.
Aim
The aim of this project was to develop a framework to identify and categorize the types of decisions for which health systems might seek external evidence, including evidence regarding health care delivery and organization, using the following questions: a. What is the nature of the decision? b. What is the level of evidence required by health systems? i. What types of evidence would be needed for each type of decision? ii. What type of review, format and time frame would be needed? c. Who is involved in the decision? d. Are there types of decisions where EPC reports could substantially improve the decisionmaking process and quality of care in health systems?
Data Sources
The data used in this study come from three sources: (a) literature search, (b) original data on evidence synthesis requests made to four evidence synthesis programs serving health systems, and (c) input from two health system stakeholders and EPC investigators, obtained during a faceto-face meeting at AHRQ in June 2017. A second workgroup's report addresses this topic through interviews with health system stakeholders.
Literature Search
Eligible publications summarize original data or present reviews, commentaries and opinion pieces that describe the research evidence needs of health systems. We defined a health system as at least one hospital and one group of physicians; or two or more health care provider organizations with common ownership, contractual integration (e.g., accountable care organizations) or formal referral arrangements. Eligible publications addressed who in a health system requested research evidence, what type of research evidence was requested, or why it was requested. We excluded non-English publications and those focusing on single health systems using their own local administrative or clinical data exclusively, rather than external research evidence, to inform decisions. We included studies from non-U.S. systems where the decisions were deemed to be similar to those faced by U.S. systems (e.g., U.K., Australia, Canada), but excluded those where the decisions are significantly different from those faced by U.S. systems.
We We identified additional references by reviewing bibliographies of relevant studies and contacting experts. References were uploaded into Abstrackr 12 and dually reviewed for relevance using predetermined criteria. We extracted data on the characteristics of health systems, the individuals asking questions, payment or policy incentives informing questions and approaches, and types of research evidence used to address questions.
Original Data
A convenience sample of evidence synthesis review groups serving U.S. health systems was asked to provide a summary of the reviews performed for health systems over the last several years. These groups serve: Kaiser Permanente Southern California, a large integrated health system and not-for-profit health plan serving over 4.5 million members in Southern California; the Veteran's Health Administration (VHA), the largest integrated health care system in the United States; ECRI Institute, a not-for-profit health services research organization that conducts reviews for health systems, payers and provider groups under commission or subscription; and Penn Medicine, a large academic health system in Philadelphia, Pennsylvania. Information requested included the number and types of requests received for evidence syntheses, as well as the specialty and topic area of the requests.
Stakeholder Feedback
Two health system representatives (Lucy Savitz, Ph.D., from Intermountain Health Care and Kaiser Permanente Northwest, and Charles P. Friedman, Ph.D., Chair of the Department of Learning Health Sciences at the University of Michigan) were invited to review the approach and results of this work group and provide feedback. Additional stakeholder feedback was obtained from a second EPC workgroup that had conducted interviews with representatives of other health systems.
Synthesis
Data were synthesized narratively and thematically. We started by developing an initial framework to guide discussion and analysis (See Appendix B). We used weekly phone conferences, electronic communications and a face-to-face meeting of the workgroup to reach consensus on the initial framework and to modify it based on the three data sources. A summary of the research question and approach is depicted in Figure 1 
Aim
To develop a framework for understanding evidence needs of health systems (What evidence is being requested, why and by whom? How can evidence synthesis be adapted to fit the needs of health systems?)
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Literature Review
From 1,591 candidate references, 166 were deemed relevant and reviewed in full text, and 46 articles were included. Eighteen of the studies contained original data, 11 were narrative reviews, 9 were commentaries or editorials, and 6 included their own frameworks for categorizing types of evidence needs or decisions made in the health system context.
Types of Questions/Decisions for Which Health Systems Seek Evidence
Three articles provided a broad categorization of evidence needs of health systems. Makkar 2015 13 provides a framework with four ways in which research is used in decisionmaking: (1) to prioritize issues or actions; (2) to provide new ideas, understanding, or concepts to clarify thinking without directly influencing decisions; (3) to persuade stakeholders or to justify decisions; and (4) to meet external requirements, such as regulatory or funding mandates to use research evidence (e.g., Magnet status for hospitals). Ølhom 2015 14 describes a systematic review of studies on the information needs of hospital managers for a European initiative (AdHopHTA) to strengthen the use of HTA by hospitals. They identified 74 types of information needs and categorized them into ten domains: health problem and current use of technology, description and technical characteristics of technology, clinical effectiveness, safety aspects, costs and economic evaluation, and ethical, organizational, social, legal, political and strategic aspects. Following the completion of the systematic review, the same researchers conducted face-to-face interviews with 53 hospital managers in 9 European countries to understand the managers' information needs regarding investments in new health care technologies. 15 The most commonly cited needs were in the clinical effectiveness and economic domains, namely reimbursement and budget impact analysis, not societal level cost-effectiveness analysis. Interviewees also mentioned interest in the political and strategic domain, particularly regarding the hospitals' strategic research priorities, prestige-building, competition with other hospitals, and investments.
Studies that reported on questions and decisions for which health systems seek evidence are summarized in Evidence Table C-1 in the Appendix. The studies show that health systems' questions can be asked at various levels, including the level of a committee, a unit/practice, department, hospital, or a whole health system level. Thematic review of the available studies demonstrates that the various categorization approaches converge into three overlapping areas. In Box 1, we summarize the three categories of decisions and questions for which health systems seek evidence. 
Adoption of Medical Technology
Much of the literature on decisionmaking and use of evidence in health systems focuses on the acquisition of health care technology (i.e., drugs, biologics, devices, equipment supplies, procedures, programs, support systems). 16 Luce and Brown describe the results of a survey of 30 organizations including hospitals, health maintenance organizations (HMOs), public and private payers, and group purchasing organizations (GPOs). Participants from hospitals cited decisions on purchasing, controlling costs, marketing, and avoiding early obsolescence as reasons for their use of HTAs. 17 Health maintenance organizations noted their obligation to cover interventions once they become "standard medical care" rather than "experimental" as impetus for decisions about examining new health care interventions.
Studies from the United States, United Kingdom and Australia showed that formulary decisions were one of the most common decisions for which health systems commonly required evidence. 18, 19 In one study, the most common technologies reviewed by HTA programs were drugs (24%), devices (19%), and care processes (12%). 18 Service managers in Australia considered safety and effectiveness the most important criteria when introducing or discontinuing new technologies. However, they acknowledged that budgetary considerations heavily influenced decisions about the uptake and diffusion of new technologies. 20 Budget allocation and investment decisions were common reasons for seeking evidence in studies of hospital-based HTA included in a review by Gagnon. 21 Several other studies described decisions for which organizations requested evidence syntheses, including choices between alternatives when standardizing products across a system, and choosing between vendors or manufacturers of similar products. 18-24 A health system in Australia sought evidence to inform decisions about disinvesting in technologies and practices. 25 
Health Services Offerings
Several studies described use of evidence in strategic decisionmaking and implementation. Examples included addressing inequalities and disparities through developing new community programs and service lines. 26 A clinical service line is an organizational strategy for planning, marketing and delivering multidisciplinary health care services defined by a clinical intervention, health condition, or population group. 27 Others described initiatives for improving quality and safety of care by putting new processes in place, using tools such as clinical pathways. Several other studies reported evidence requested for determining implementation strategies for clinical programs or policies. 18, 19, 22, 28, 29 When researchers in British Columbia, Canada, gathered researchers and decisionmakers from various levels in the six provincial health authorities to consider priority setting for future research in health care, 30 they learned that staff were concerned about deciding how to effectively make decisions and set priorities, suggesting a need for evidence about the process of decisionmaking in health systems.
Governance, Finance and Delivery Models
Lavis 2010 11 reviewed an inventory of HTAs produced by nine agencies during 2003-2006 and interviewed Canadian health care managers and policy makers. Decisions about governance, financial, and delivery arrangements require research evidence to inform problem definition, option framing and assessment, and implementation plans.
Several studies describe evidence needs in these categories. Cumpston and colleagues 2012 examined the work of the Cochrane Effective Practice and Organisation of Care (EPOC) group, which focuses on systematic reviews of professional, financial, organizational and regulatory interventions for improving practice and organization of health care services. 31 After reviewing published EPOC review topics, the authors surveyed Australian health policymakers to identify gaps in the topics covered, and summarize their findings using the EPOC categories. Examples of the structural category include the need for evidence on interventions to improve population health and evidence to help the health system predict future demands for health services. Health systems the need to predict future demand to prepare for workforce recruitment, organization, and training, as well as to plan for infrastructure needs. 31 Provider-oriented evidence needs include topics such as defining roles for allied health professionals and hospitalists, recruiting minorities to the workforce, and improving cultural competence. Patient-oriented needs include interventions to improve access and to serve special populations (e.g., rural, indigenous, refugees, prisoners) and interventions to promote community engagement in health service planning. Regulatory topics include the impact of credentialing of health professionals on safety and quality of care, and identifying interventions to improve coordination of services when there are multiple payers/funders involved. 31 In addition, the authors of this and other studies identified the need for evidence to support financial decisions, including topics such as the impact of different funding models and financial incentives on demand for, quality of, and access to care. 31, 32 Makkar 2015 identified the need for evidence to support the response to organizational or legislative mandates. 13 A survey of the operational partners of the U.S. Veterans Health Administration's Evidencebased Synthesis Program (VA ESP) showed that rapid reviews (median completion time 14.5 weeks) were commonly (72%) requested in response to regulatory and policy directives. 28 For example, a report that evaluated the quality of care provided by advanced practice nurses was requested to inform consideration of practice authority expansion. 28
Types of Evidence Synthesis Sought by Health Systems
Several studies have examined types of products or formats of evidence syntheses intended for use by decisionmakers. In one previous EPC methodology project, rapid review products were categorized based on extent of synthesis. "Inventories" listed what evidence is available. 7 "Rapid responses" presented best available evidence such as systematic reviews and health technology assessments with no formal synthesis. "Rapid reviews" synthesized the quality of and findings from the evidence, often including primary studies. "Automated approaches" generated meta-analyses in response to user-defined queries. 33 In a second EPC methodology project, several end-users were interviewed (key informants including guideline developers, health care providers/health system organizations, research funders, and payers/health insurers). 10 Informants described the use of evidence inventories "to stimulate discussion, challenge the status quo or get a sense of the literature when there is a pressing concern." They reported that "rapid responses and rapid reviews may be more relevant for issues (often narrow questions) that arise within the clinical setting specific to a health system (where it may be more feasible to narrow the scope), or when interest is focused more on implementation (e.g., tailoring the evidence to a given region/setting)." One interviewee describing the tension between rigor and efficiency stated, "operationally-oriented folks are willing to take a risk on the absolute correctness of the answer in order to do something and to do it reliably across the delivery system."
The VHA ESP surveyed health system leadership about their use of the program's rapid reviews. 28 There was a high level of agreement that the rapid reviews were influencing the delivery system. A similarly designed study in a large academic health care system suggested the same. 18 Members of Pharmacy and Therapeutics committees (pharmacists and physicians from various health systems and organizations) participating in focus groups 34 were asked about their use of AHRQ EPC Program Comparative Effectiveness Reviews (CERs). Only 26% reported using the reviews in their organizations. Participants described them as not being sufficiently timely, specific, or conclusive for their purposes. Pharmacy and Therapeutics committees usually review new products, whereas CER reviews are more useful for evaluating therapeutic classes of existing drugs. The wide focus and lack of specificity were a challenge to use when making specific decisions. They also commented on the need for more decisive information whereas most CER reports were perceived to be inconclusive.
Wye 2015 35 studied the use of evidence by local policymaking bodies in the U.K. and pointed out that many academic research products are not relevant to their decisions, arguing that generalizable evidence lacks local context: "Local information often trumped national evidence, academic research or information from other localities." Commissioners, "will always struggle to apply systematic reviews and randomized controlled trials, because paradoxically the very qualities that create such context-free, gold standard research render the studies less useful to commissioners." 35 Instead, "commissioners want "killer" stories that are rich in context." 35 In contrast, VHA executive level policymakers and their staff preferred RCTs, but also valued other types of evidence, such as case studies and patient preference studies. 36 Others also mentioned the need for local contextual information or applicability information, and descriptions of the uncertainty of the findings. 11, 35 Such contextual information is critical for decisionmaking and is consistent with the GRADE Evidence to Decision framework, which describes several discrete factors, other than effectiveness evidence, needed to make decisions (e.g., cost effectiveness and resource use, equity, acceptability, feasibility and values). 37 In contrast, other health services researchers experienced in engaging policymakers and health care managers argue that systematic reviews can be useful to these groups, and compiled a list of "myths" about the suitability of systematic reviews for use by decisionmakers. 38 They attempted to counter these myths by reviewing evidence included in the Canadian Health Systems Evidence Website (www.healthsystemsevidence.org), which covers topics including governance, financial arrangements, delivery arrangements, and implementing change in health systems. While acknowledging that more systematic reviews addressing policymakers' questions are needed, they argued that systematic reviews can "level the playing field" when there are multiple stakeholders with different points of view. When all interested parties work from the same evidence, engagement is more likely. They also argued that "empty" systematic reviews (i.e., systematic reviews with no eligible studies to answer the question at hand) could be useful for decisionmaking. Finally, they note that exploring heterogeneity in systematic reviews can facilitate understanding about why interventions work in some settings and not others.
Additional descriptions are provided in Evidence 
Tools for Promoting Use of Evidence in Health System Decisions
Although this question was not included in the initial proposed framework, the literature review suggested that this issue is likely important for health systems and can optimize their use of evidence. Gagnon 2014 conducted a systematic review of instruments to assess organizational readiness for knowledge translation in health care, identifying 26 instruments. 39 A number of studies described self-assessment tools for use by health systems decisionmakers to evaluate readiness and resources for utilizing evidence in decisions (e.g., Catallo 2014 40 , Lefebre 2010, 41 Gifford 2014 42 , Gagnon 2014 39 )
Perrier 2011 43 et al conducted a systematic review on interventions encouraging the use of systematic reviews by health policymakers and managers. In the single randomized trial identified, Dobbins 2009 44 found that showing tailored messages combined with access to a registry of systematic reviews had a significant effect on policies made in a health department in Canada.
Ellen 2014 45,46 2013 47 used surveys and qualitative studies to determine the barriers and facilitators for using evidence in health system decisionmaking. Establishing an environment that is conducive to use of evidence includes appropriate infrastructure, facilitating "push" efforts by knowledge brokers to disseminate research evidence to potential users, "pull" efforts by health system decisionmakers, "linkage and exchange" efforts facilitating relationships between researchers and knowledge users, and evaluation of knowledge translation efforts. Innis 2015 48 also reported on such barriers and facilitators in a scoping review that emphasized the importance of organizational culture, leadership, linkage of evidence use to the organization's strategic direction, presence of champions and appropriate infrastructure.
The focus group study with Pharmacy and Therapeutics committee members mentioned previously found the participants were interested in attending or completing a CER training program to help them use CER reviews in preparing evidence summaries for decisionmaking. In particular, they wanted training in evaluation of "evidence hierarchies," and wanted online course delivery. 34 In several studies, decisionmakers were interviewed or observed to identify preferences for presentation format. In general, they preferred summaries that were brief, presented in a "graded" format (key messages, executive summary) or presented verbally. 11, 18, 22, 35 Two systematic reviews 49, 50 addressed decisionmakers preferences for various derivative products based on systematic reviews. One found that decisionmakers described summary of findings tables with event rates and absolute differences as preferable. 49 The other found that mailed bulletins with synopses of systematic reviews that were distributed to clinicians were associated with some practice improvement. 50 Wye 2015 studied the use of evidence by local policymaking bodies in the U.K. and noted that policymakers preferred verbal over written presentation. 35 As described previously, health system decisionmakers often expressed a desire for more "conclusive" and "decisive" evidence. Studies by Makkar 2015 13 , Aicken 2012 51 , Goetghebeur 2008 52 , Munn 2014 53 , and Munn 2014 53 described approaches that may address this perceived need by providing tools such as multicriteria decision analysis (MCDA), conjoint analysis, decision analytic modelling, or other quantitative approaches to clarifying value judgments and incorporating evidence. These approaches would require partnership between evidence synthesis producers and health systems capable of manipulating and processing the evidence to make local decisions.
Box 3. Characteristics of tools for promoting use of evidence syntheses by health systems
• Preparation for using evidence: system self-assessment tools for use of evidence and knowledge translation •
Customized information delivery and access to information resources •
Health system infrastructure and local champions for use of evidence in decisionmaking • Layered format that allows different users with different needs to access formats that range from a highly focused presentation to highly detailed information • Preference for event rates, natural frequencies, and absolute differences, over relative measures • Oral presentation of report findings to users • Training and education for users
The studies relevant to this domain are found in Evidence Table C-3 in the Appendix.
Original Data
Original data were available from four evidence synthesis programs that addressed the research evidence needs of individual health systems: Kaiser Permanente Southern California (KPSC), Veterans Health Administration (VHA) Evidence Synthesis Program (ESP), ECRI Institute's Health Technology Assessment Information Service (HTAIS), and Penn Medicine Center for Evidence-based Practice (CEP). The experiences of these four centers are summarized in Table1.
The number of products created annually by each center varied widely, from over 300 products a year for organizations like ECRI and KPSC that performed rapid reviews and served a large number of hospitals, to approximately 30 a year for Penn CEP, which performs rapid reviews but serves fewer hospitals, to less than 20 a year for the VHA ESP, which commonly performs traditional reviews for the national VA program. Many requests received by ECRI Institute did not lead to the generation of new evidence reports (205/702, 29%), and the requestor was directed to existing systematic reviews, evidence reports or other resources. Rapid products were the most common product performed except at the VHA (93% of the ECRI HTAIS reports within 10 to 15 business days, 60% of KPSC reports within 1 to 5 days as required by regulation for addressing patient requests, 86% of Penn Medicine CEP reports within 3 months). A wide range of clinical and administrative decisionmakers requested evidence reviews, and the topics were similarly broad-ranging from evidence to guide clinical care; purchasing of medications and devices; procedural and non-procedural interventions; and processes of care. Topics addressed by each organization were dictated by the needs of their requestors or strengths of the organization. For example, almost 70% of the VHA ESP reports addressed care processes, policies or non-drug, non-device interventions, while approximately 90% of ECRI reports addressed devices, procedures, implants, tests or other technologies. Data suggest that those requesting reports and the types of topics examined have changed over time as well. For example, the proportion of reports performed by the Penn CEP that were relevant to nursing practice increased from 6% (2/35) Experience from the four centers is summarized in Table 1 . 
Stakeholder Feedback
Two health system representatives, Lucy Savitz, Ph.D., M.B.A. and Charles P. Friedman, Ph.D. provided feedback on our initial framework and draft report. Our stakeholders' perspectives on how the EPC program can best interact with learning health systems can be summarized in the following themes:
Trustworthiness
Drs. Savitz and Friedman introduced a new domain to the framework-trustworthiness of evidence. This trustworthiness was described in two ways:
• How trustworthy is the evidence? Health systems making decisions based on the evidence need to know the reviewers' level of confidence in the estimates of effect provided in the evidence summaries. This description is analogous to the strength of evidence (SOE) levels used by the EPC program when conducting systematic reviews. • How trustworthy is the evidence synthesis group and how credible is the review process?
Stakeholders emphasized the importance of trust and partnership between the health system and the evidence synthesis team and voiced that such trust is critical to acceptance of evidence summaries by health systems. They also mentioned that a system might not trust the assigned SOE if it contradicts data or observations derived from their local setting. They expressed the concern that excessive labeling of evidence as low or insufficient is, in general, not helpful to health systems because they need to make decisions and act in real time, and cannot wait for future studies. They also mentioned the need for evidence summaries that present more decisive and practical results.
Evaluation and Feedback
These health systems' representatives described the need for evaluation, reassessment and feedback about the use of evidence in health systems. Such evaluation serves as a tool for continuous quality improvement, can close the loop on evidence uptake, and demonstrate barriers for using summarized evidence in decisionmaking. They described a conceptual model in which knowledge is available in a machine executable form, and a learning cycle in which data transitions to knowledge, then knowledge transitions to practice, and finally practice provides additional data and process feedback.
Preparing Evidence for Use by Learning Health Systems
Drs. Savitz and Friedman suggested a role for evidence synthesis producers to assist in packaging and continuously updating evidence for real-time use by clinicians and other decisionmakers in learning health systems, with the vision of incorporating evidence into health information technology systems of the future. Such a role aligns with the concept of learning health systems.
Engaging Health System Networks
Our health systems stakeholders mentioned a possible need for evidence synthesis programs to engage with networks of health systems (e.g., High Value Healthcare Collaborative) and data analytics services (e.g., Flatiron Health, ASCO CancerLinQ™), which may help identify and address research evidence needs across health systems as they evolve and change.
Layered Knowledge Presentation
Drs. Savitz and Friedman corroborated the importance of layered information that starts with key messages (which are important for certain types of users within health systems) followed by information that is more detailed (for other users who want to focus on implementation or have other particular needs).
Internal and External Evidence
Our stakeholders clearly differentiated between external evidence (summarized from published literature) and internal evidence (derived from the system's own electronic health records or other local datasets), and expressed the importance of both types of evidence.
Evidence Synthesis Producer Engagement With Health Systems
Lastly, Drs. Savitz and Friedman requested that this workgroup provide, in addition to a framework, recommendations that facilitate engagement of evidence synthesis producers with health systems.
Discussion
In this report, we sought to develop a framework to facilitate understanding of the areas of potential interaction between evidence synthesis producers and health systems. After using several data sources including published literature, original data from evidence synthesis programs, and obtaining feedback from health systems stakeholders, we identified several domains that may help facilitate interaction between health systems and evidence synthesis producers and may aid in providing evidence summaries catered to the needs of health systems.
Successful engagement will require specifying the following:
• type of decision or question(s) of the health system, • type of evidence synthesis or evidence synthesis product that will best address the question, o evidence synthesis users within the health system o optimal timing for evidence synthesis delivery during the decisionmaking process • tools required to promote the use of evidence (which could be developed by the evidence synthesis program or by the health system), and finally a • feedback or auditing mechanism to determine the success and impact of evidence integration into health system decisions. Trustworthiness of the process of the evidence synthesis and communication of the trustworthiness of the evidence is an additional key domain.
These domains can serve as a taxonomy and facilitate engagement with the health system ( Figure 2 ).
Figure 2. Domains or parameters to be specified for engagement of evidence synthesis programs with health systems
Type of Health System Decision/Question
Type of Required Evidence Synthesis o Delivery timing o Recipients
Trustworthiness of Evidence and Evidence Synthesis
Tools for Promoting Use of Evidence
Evaluation and Feedback
Key Points
• Our review suggests that health system leaders' decisions for which evidence is needed commonly include the acquisition of medical technology, including interventional devices and pharmaceutical interventions; the implementation or expansion of service line offerings; disinvestment and deimplementation of technologies: improvements in care processes; and the selection of governance, finance and service delivery models. • Health systems often are interested in evidence for newer and emerging interventions.
• Health systems often require evidence summaries that are completed rapidly (i.e., in 4-12 weeks or less) with succinct, easy-to-grasp conclusions with practical guidance for action even if the evidence is weak or inconclusive, and layered information presentation. • Partnerships and reciprocal trust are essential for collaboration between evidence synthesis producers and health systems. • For evidence to be believable and implementable by a health system, evidence synthesis producers should present it with the local and operational context in mind.
The Learning Health System Context
Much of the discussion about learning health systems focuses on the tremendous amounts of data each system can generate from patient encounters, including genomic data. 54 In addition to using data within an individual system, learning health systems are forming data networks with a goal of generating new knowledge across organizations. However, there is clearly a role for synthesized external evidence in promoting the learning process. As described in one of the reports in the IOM series on learning health care systems, "A learning health care system depends on evidence to promote improvements in care delivery processes and patient care and overall system improvement. Consequently, health researchers are critical partners in generating knowledge on the effectiveness and value of interventions and care protocols." 55 McGinnis, writing about the application of evidence-based medicine to learning health systems, describes a process in which systems with effective clinical data systems capture patient outcomes resulting from "best practice" and feedback the lessons to generate new knowledge that will facilitate customization for individual patients. 1 This interaction between external and internal evidence is critical in learning health systems. This echoes what we heard from our health systems' experts, who clearly differentiated between external evidence (i.e., from the research literature) and internal evidence (derived from the system's own electronic health records or other local datasets) and expressed the need for both types of evidence. External evidence can provide the overarching comparative effectiveness inferences with strength of evidence (SOE) ratings, whereas internal evidence is useful to contextualize the external evidence and aid in its implementation. Internal evidence may also help fill the research gaps of external evidence. Mitchell 2010, writing about the Penn Medicine CEP has described their experience gathering external evidence and supplementing with collection of local evidence and contextual information from the health system. 56 In a workshop held by the IOM on "engineering a learning healthcare system, 55 Brent James described the process for integrating evidence into clinical care at Intermountain Healthcare. After identifying high priority clinical processes, defined by volume and risk to patients, the organization charges teams with developing evidence-based guidelines that can be embedded in the clinical workflow. Intermountain is able to measure variance from these "shared baselines" which is used to understand the degree of variation based on patient factors versus professional factors. He noted that typically 5 to 15 percent of the content of these protocols is routinely adapted to meet the needs of individual patients, an approach known in quality theory as "mass customization." Evidence synthesis producers could collaborate with health systems to help to summarize evidence for such protocols. After implementing protocols, health systems could provide data back to evidence synthesis groups for analysis of variations and updating of the evidence with this internal evidence as well as more recently published external evidence.
Even sophisticated health systems may need assistance identifying best practice. For example, Raymond Baxter of Kaiser Permanente described an effort to gather input from clinical leaders in the Kaiser health system to find the questions for which they needed answers to meet the "triple aim": (1) Improving health care for individuals along six dimensions [safety, effectiveness, patient-centeredness, timeliness, efficiency, and equity]; (2) Improving the health for populations by attacking causes of ill health such as poor nutrition, physical inactivity, and substance abuse; and (3) Reducing, or at least controlling, the per capita cost of care. 57 He received 342 questions from across the organization. Baxter was surprised to learn that "between 25 and 30 percent of the questions already had answers, though the evidence was not known or available to those who proposed those questions." 58 One mechanism for delivering evidence-based guidance at the point of care is clinical decision support. Collaborations between evidence synthesis programs and clinical decision support developers are important for understanding the best ways to deliver syntheses for this purpose. Guideline syntheses, in which different approaches to care of patients with similar conditions are analyzed and harmonized alongside current evidence, may be useful products for this purpose. Another possible strategy is synthesis of evidence to inform quality or performance measures. In either case, feedback from health systems to evidence synthesizers about the outcomes of care would be critical for real improvements in patient care.
The belief that evidence synthesis producers only consider randomized controlled trials conducted in highly selected populations was noted in the literature and in discussions with the health system experts. The EPC Program, like other evidence synthesis programs, has called for inclusion of nonrandomized studies and other observational studies as a matter of course. 59 Unfortunately, the perception persists that evidence syntheses are unlikely to address "real world" situations. The Program has recently invested in methods development for evaluating complex multicomponent interventions, 3-9 much of which is applicable to the concerns of health systems. Other work has addressed ratings of SOE for complex interventions 60 and for synthesizing evidence when meta-analyses are not possible; 61 both scenarios are common for interventions considered by health systems. Other authors have provided similar arguments suggesting that a broad definition of evidence including observational studies is necessary for external evidence to be used in system level decision making; 62 and attributing the lack of use of evidence by system level decisionmakers to the historical focus of evidence producers on individual clinicians' needs (as opposed to operational, delivery and policy needs). 63 In describing core features of the learning health system envisioned by the IOM Roundtable on Evidence-based Medicine, McGinnis discusses the need for a "trusted scientific intermediary" that can "broker the perspectives of different parties" in determining what constitutes best practice and how such evidence should be interpreted and applied. 1 This echoes the point made by our stakeholders that health systems need assurance of the trustworthiness of both the evidence and the evidence synthesis producers.
Although the full series has not yet been published, Harris and colleagues at the Australian public health system, Monash Health, have begun to report their experience with such a process. This health system, which includes six hospitals and multiple outpatient and long-term care facilities, operates under a state determined fixed budget. In response to economic pressures, the Monash Health Centre for Clinical Effectiveness (CCE), an Evidence Based Practice (EBP) Hospital Support Unit, undertook the Sustainability in Health care by Allocating Resources Effectively (SHARE) program to approach disinvestment in practices that are unsafe, inefficient, ineffective, or less effective than alternatives. This series of publications describes the steps taken by the system to identify opportunities for change, develop proposals for supporting the change, implement the proposals, and evaluate the extent and impact of the change. The authors state "Each step is underpinned by the principles of evidence-based practice to ensure that the best available evidence from research and local data, the experience and expertise of health service staff and the values and perspectives of consumers are taken into account." Although authors do not use the term "learning health system" in the papers, it is clear that the goal of the project is to create a system that implements evidence, learns from the implementation, and feeds that learning back into the system and larger health care community. 25, 64, 65 In summary, gaps exist between the needs of health systems and traditional evidence synthesis products in terms of topics covered, formats in which the synthesis is presented, and time for production. Evidence synthesis programs can support health systems by providing rapid, focused and layered summaries, addressing a broad range of topics of relevance to health systems, and by including contextual and operational evidence from local sources when available. Evidence synthesis producers need to strengthen their partnerships with health systems to better understand their evidence synthesis needs and to determine the most appropriate synthesis products for particular systems and decisions. We have proposed a framework to facilitate discussion to this end.
Based on our review and interaction with stakeholders from health systems, we next offer several recommendations for how the AHRQ EPC Program can better support health systems' uptake of evidence.
Recommendations for the AHRQ EPC Program
The IOM challenged research funding agencies to promote research into barriers to use of evidence at the point of care and to support research methods for improving the usefulness and accessibility of local (patient outcome data) and external (published research) evidence for patients and clinicians. 66 Our work group discussed possible roles for the AHRQ EPC Program in meeting the evidence needs of learning health systems in the United States. Methods work already performed by the Agency that is relevant to decisionmaking by health systems includes work on methods for synthesis of evidence on complex interventions, such as interventions used by health systems to support quality improvement and healthcare delivery. Other methods research performed by the AHRQ EPC program relevant to health systems are those projects related to the production of rapid evidence synthesis products, including projects on rapid reviews and horizon scanning.
The former AHRQ Director, Dr. Andrew Bindman, commented that most health care organizations need help to develop processes to adopt and generate evidence. He stated that AHRQ "is the federal agency best positioned to serve as a facilitator that can help health care organizations make this transition [to learning health care systems]," based on the Agency's experience developing methods for evaluating quality of evidence. He proposed that health systems could use these methods to judge the quality of both internal and external published evidence. He suggested that AHRQ could engage with health systems in "collaborative problem solving" as a means of learning how to support them. 67 We considered roles that may be both desirable and feasible for AHRQ, given budgetary constraints and the complexity of current contracting mechanisms, and offer the following suggestions:
1. Create a standing advisory committee of health system leaders who can advise AHRQ , and create a flag or icon next to those reports. d. For those reports meeting criteria of particular interest to health systems, a health system implementation toolkit could be published alongside the original report. 4. Involve interested health system partners and decisionmakers in the scoping for reviews they have nominated to identify their highest priority needs, with a goal of producing reviews that are focused, timely and relevant. 5. Leverage previous program experience with horizon scanning, topic briefs developed for program planning, and methods work on rapid reviews to develop new evidence synthesis products tailored to health systems. Engagement of health systems in the development process may promote trustworthiness in the EPC program, evidence synthesis process, and resulting product. 6. Shorten the time required to produce evidence reviews while maintaining a systematic rigorous approach. This could include a. More flexible contractual mechanisms such as non-competitive assignments for evidence products or allowing for bundling of topics so contracting only has to be done once (e.g., one EPC will do 3 brief products in a 6-12 week time frame over the next 6 months) b. Reduction of the various layers of public, peer and intra-agency review of reports c. Reorganization of the production process. 7. Consider when certain types of contextual information, including information on intervention components, intervention implementation, and feasibility, should be included in EPC Program reviews to improve usefulness 
Appendix C. Evidence Tables
Appendix Table C Evaluating the extent and impact of change Specific example described is disinvestment of practices that are • Unsafe • Ineffective, or less effective than better alternatives • Inefficient Method involves integrating external evidence and local internal evidence, supported by an Evidence-based Practice Hospital Support Unit within the system (several papers still in press at time of writing this report, including a paper on the role evidence synthesis) Jackson 2013 69 U.S. (VHA) Descriptive (quality improvement collaborative within VHA) • Evidence to inform quality indicators for assessing (and improving) quality of care Jayakumar 2016 18 Mitchell 2011 22 Umscheid 2010 19 U.S., Academic medical centerbased HTA unit One case report, one commentary, and one descriptive study including an institutional survey • Identifying best practices for institutional decisionmaking • Decisionmaking includes formularies, supplies, and process of care • Implementation through quality improvement and computerized decision support initiatives
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